These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 29475917)

  • 21. From conventionally fractionated radiation therapy to hyperfractionated radiation therapy alone and with concurrent chemotherapy in patients with early-stage nonsmall cell lung cancer.
    Jeremić B; Milicić B
    Cancer; 2008 Feb; 112(4):876-84. PubMed ID: 18172901
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A phase II study of concurrent carboplatin and paclitaxel and thoracic radiotherapy for completely resected stage II and IIIA non-small cell lung cancer.
    Feigenberg SJ; Hanlon AL; Langer C; Goldberg M; Nicolaou N; Millenson M; Coia LR; Lanciano R; Movsas B
    J Thorac Oncol; 2007 Apr; 2(4):287-92. PubMed ID: 17409799
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phase I study to determine the maximum-tolerated dose of radiation in standard daily and hyperfractionated-accelerated twice-daily radiation schedules with concurrent chemotherapy for limited-stage small-cell lung cancer.
    Choi NC; Herndon JE; Rosenman J; Carey RW; Chung CT; Bernard S; Leone L; Seagren S; Green M
    J Clin Oncol; 1998 Nov; 16(11):3528-36. PubMed ID: 9817271
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cost-utility analysis of short- versus long-course palliative radiotherapy in patients with non-small-cell lung cancer.
    van den Hout WB; Kramer GW; Noordijk EM; Leer JW
    J Natl Cancer Inst; 2006 Dec; 98(24):1786-94. PubMed ID: 17179480
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Short-course palliative radiotherapy in non-small-cell lung cancer: results of a prospective study.
    Lupattelli M; Maranzano E; Bellavita R; Chionne F; Darwish S; Piro F; Latini P
    Am J Clin Oncol; 2000 Feb; 23(1):89-93. PubMed ID: 10683087
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The treatment of stage III nonsmall cell lung cancer using high dose conformal radiotherapy.
    Sibley GS; Mundt AJ; Shapiro C; Jacobs R; Chen G; Weichselbaum R; Vijayakumar S
    Int J Radiat Oncol Biol Phys; 1995 Dec; 33(5):1001-7. PubMed ID: 7493826
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Is intermediate radiation dose escalation with concurrent chemotherapy for stage III non-small-cell lung cancer beneficial? A multi-institutional propensity score matched analysis.
    Rodrigues G; Oberije C; Senan S; Tsujino K; Wiersma T; Moreno-Jimenez M; Kim TH; Marks LB; Rengan R; De Petris L; Ramella S; DeRuyck K; De Dios NR; Warner A; Bradley JD; Palma DA
    Int J Radiat Oncol Biol Phys; 2015 Jan; 91(1):133-9. PubMed ID: 25835622
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A phase I clinical trial of thoracic radiotherapy and concurrent celecoxib for patients with unfavorable performance status inoperable/unresectable non-small cell lung cancer.
    Liao Z; Komaki R; Milas L; Yuan C; Kies M; Chang JY; Jeter M; Guerrero T; Blumenschien G; Smith CM; Fossella F; Brown B; Cox JD
    Clin Cancer Res; 2005 May; 11(9):3342-8. PubMed ID: 15867233
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Safety and palliative efficacy of single-dose 8-Gy reirradiation for painful local failure in patients with stage IV non-small cell lung cancer previously treated with radical chemoradiation therapy.
    Topkan E; Yildirim BA; Guler OC; Parlak C; Pehlivan B; Selek U
    Int J Radiat Oncol Biol Phys; 2015 Mar; 91(4):774-80. PubMed ID: 25752391
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Accelerated hypofractionated thoracic radiotherapy in limited disease small cell lung cancer : comparison with the results of conventionally fractionated radiotherapy.
    Socha J; Guzowska A; Tyc-Szczepaniak D; Wierzchowski M; Sprawka A; Szczesna A; Kepka L
    J BUON; 2015; 20(1):146-57. PubMed ID: 25778310
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Palliative Lung Radiotherapy: Higher Dose Leads to Improved Survival?
    Lewis TS; Kennedy JA; Price GJ; Mee T; Woolf DK; Bayman NA; Chan C; Coote JH; Faivre-Finn C; Harris MA; Hudson AM; Pemberton LS; Salem A; Sheikh HY; Mistry HB; Cobben DCP
    Clin Oncol (R Coll Radiol); 2020 Oct; 32(10):674-684. PubMed ID: 32600918
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Prognosis of locally advanced non small cell lung cancer treated with three dimentional conformal radiotherapy].
    Zhu XZ; Wang LH; Ou GF; Zhou ZM; Chen DF; Xiao ZF; Feng QF; Zhang HX; Wang M; Yin WB
    Zhonghua Zhong Liu Za Zhi; 2007 Oct; 29(10):748-53. PubMed ID: 18396686
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Results and prognostic factors of hypofractionated stereotactic radiation therapy for primary or metastatic lung cancer.
    Kim H; Ahn YC; Park HC; Lim DH; Nam H
    J Thorac Oncol; 2010 Apr; 5(4):526-32. PubMed ID: 20104193
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of curative and palliative radiotherapy efficacy in unresectable advanced non-small cell lung cancer patients with or without metastasis.
    Unlu I; Diniz G; Komurcuoglu B; Gayaf M; Gokce T; Karadogan I; Akcay C
    Saudi Med J; 2006 Jun; 27(6):849-53. PubMed ID: 16758049
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Steep dose-response relationship for stage I non-small-cell lung cancer using hypofractionated high-dose irradiation by real-time tumor-tracking radiotherapy.
    Onimaru R; Fujino M; Yamazaki K; Onodera Y; Taguchi H; Katoh N; Hommura F; Oizumi S; Nishimura M; Shirato H
    Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):374-81. PubMed ID: 18029106
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of the Radiation Dose on Survival after Radiochemotherapy for Small-cell Lung Cancer.
    Käsmann L; Janssen S; Schild SE; Rades D
    Anticancer Res; 2016 Mar; 36(3):1089-91. PubMed ID: 26977003
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic significance of C-reactive protein and smoking in patients with advanced non-small cell lung cancer treated with first-line palliative chemotherapy.
    Koch A; Fohlin H; Sörenson S
    J Thorac Oncol; 2009 Mar; 4(3):326-32. PubMed ID: 19155996
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Survival analysis of malignant epidural spinal cord compression after palliative radiotherapy using Tokuhashi scoring system and the impact of systemic therapy.
    Mui WH; Lam TC; Wong FCS; Sze WK
    Ann Palliat Med; 2017 Dec; 6(Suppl 2):S132-S139. PubMed ID: 29156895
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Accelerated radical radiotherapy for non-small cell lung cancer using two common regimens: a single-centre retrospective study of outcome.
    Pemberton LS; Din OS; Fisher PM; Hatton MQ
    Clin Oncol (R Coll Radiol); 2009 Apr; 21(3):161-7. PubMed ID: 19111452
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Re-irradiation stereotactic body radiotherapy for spinal metastases: a multi-institutional outcome analysis.
    Hashmi A; Guckenberger M; Kersh R; Gerszten PC; Mantel F; Grills IS; Flickinger JC; Shin JH; Fahim DK; Winey B; Oh K; John Cho BC; Létourneau D; Sheehan J; Sahgal A
    J Neurosurg Spine; 2016 Nov; 25(5):646-653. PubMed ID: 27341054
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.